Home › Funds › Ikarian Capital, LLC › TECX

Ikarian Capital, LLC position in TECX

TECTONIC THERAPEUTIC INC · Health Care

Ikarian Capital, LLC reported holding 205,837 shares of TECX (TECTONIC THERAPEUTIC INC) in its Q2 2026 13F filing — a position valued at US$7.1M, representing 1.14% of its reported portfolio and ranking #26 among its reported holdings. Ikarian Capital, LLC has disclosed TECX holdings in 7 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)205.84K sh
Reported value held$7.08M
Portfolio Weight1.14%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ikarian Capital, LLC's TECX position evolved

Ikarian Capital, LLC first disclosed a stake in TECX in Q2 2024 at 62,836 shares (US$1.0M). The position peaked in Q3 2024 at 267,145 shares, worth US$8.1M. Across 7 filings, Ikarian Capital, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 205,837 shares valued at US$7.1M — an increase of 48,300 shares quarter over quarter.. Notable position changes include a 325% increase in Q3 2024, a 47% trim in Q4 2024 (shares fell 62% over the following quarter), a 89% increase in Q1 2025 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 62.84K $1.03M New
Q3 2024 267.14K $8.09M Add
Q4 2024 142.33K $6.57M Reduce
Q1 2025 269.09K $4.77M Add
Q2 2025 163.70K $3.25M Reduce
Q1 2026 157.54K $4.87M New
Q2 2026 205.84K $7.08M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECX and 13F data

TECX (TECTONIC THERAPEUTIC INC) is a Health Care company. 54 other funds we track also report a position in TECX — the largest reported positions include TCG Crossover Management, LLC (US$41.4M), First Light Asset Management, LLC (US$27.5M), 5AM Venture Management, LLC (US$20.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECX

All TECX fund holders →

FAQ

How long has Ikarian Capital, LLC held TECX?

Ikarian Capital, LLC has disclosed TECX holdings in 7 of the last 9 reported quarters, going back to Q2 2024.

What is Ikarian Capital, LLC's current position in TECX?

As of Q2 2026, Ikarian Capital, LLC holds 205.84K shares of TECX (TECTONIC THERAPEUTIC INC), valued at $7.08M, representing 1.14% of its reported portfolio and ranking #26.

Has Ikarian Capital, LLC been buying or selling TECX?

In the latest 13F filing (Q2 2026), Ikarian Capital, LLC increased its position in TECX. The position peaked in Q3 2024 at 267.14K shares.

Which other funds hold TECX?

Other major institutional holders of TECX include TCG Crossover Management, LLC, First Light Asset Management, LLC, 5AM Venture Management, LLC, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.